PMID: 23259326 Girish B.N, Vaidyanathan K, Rao N.A, Rajesh G, Reshmi S, Balakrishnan V
This is where alternatives like peptide therapies start entering the conversation
Scand J Clin Lab Invest 28:91100 Gooding KM, Lienczewski C, Papale M, Koivuviita N, Maziarz M, Dutius Andersson A-M, Sharma K, Pontrelli P, Garcia Hernandez A, Bailey J, Tobin K, Saunavaara V, Zetterqvist A, Shelley D, Teh I, Ball C, Puppala S, Ibberson M, Karihaloo A, Metsrinne K, Banks R, Gilmour PS, Mansfield M, Gilchrist M, de Zeeuw D, Heerspink HJL, Nuutila P, Kretzler M, Wellberry-Smith M, Gesualdo L, Andress D, Grenier N, Shore AC, Gomez MF, Sourbron S (2020) Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
BPC-157 upregulates VEGFR2 and modulates the nitric oxide and FAK-paxillin pathways